COLLEGIUM PHARMACEUTICAL, INC Total Assets

• COLLEGIUM PHARMACEUTICAL, INC showed a decrease of -0.4% in Total Assets from 2024 to 2025.
• This data is from COLLEGIUM PHARMACEUTICAL, INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2015: $114.17 million | Q3 2015: $107.05 million | Q1 2016: $136.34 million | Q2 2016: $119.72 million | Q3 2016: $98.73 million | Q1 2017: $139.85 million | Q2 2017: $124.52 million | Q3 2017: $122.67 million | Q1 2018: $696.28 million | Q2 2018: $673.33 million | Q3 2018: $646.51 million | Q1 2019: $294.36 million | Q2 2019: $301.58 million | Q3 2019: $303.98 million | Q1 2020: $634.79 million | Q2 2020: $646.87 million | Q3 2020: $643.84 million | Q1 2021: $646.07 million | Q2 2021: $713.74 million | Q3 2021: $741.80 million | Q1 2022: $1.25 billion | Q2 2022: $1.25 billion | Q3 2022: $1.20 billion | Q1 2023: $1.21 billion | Q2 2023: $1.21 billion | Q3 2023: $1.18 billion | Q1 2024: $1.11 billion | Q2 2024: $1.05 billion | Q3 2024: $1.64 billion | Q1 2025: $1.63 billion | Q2 2025: $1.59 billion | Q3 2025: $1.61 billion.
• Over the full 12 years of available data (2014 to 2025), COLLEGIUM PHARMACEUTICAL, INC's Total Assets has grown by 32,450.8%.
• Historical annual values: Fiscal year 2025: $1.66 billion | Fiscal year 2024: $1.66 billion | Fiscal year 2023: $1.14 billion | Fiscal year 2022: $1.17 billion | Fiscal year 2021: $692.08 million | Fiscal year 2020: $643.84 million | Fiscal year 2019: $306.30 million | Fiscal year 2018: $291.25 million | Fiscal year 2017: $135.57 million | Fiscal year 2016: $162.02 million | Fiscal year 2015: $97.72 million | Fiscal year 2014: $5.09 million.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026